Aileen Cinquino

发表

Augmenting antibody response to EGF-depleting immunotherapy: Findings from a phase I trial of CIMAvax-EGF in combination with nivolumab in advanced stage NSCLC

Daniel T. Fisher, P. Wallace, I. Puzanov, 2022, Frontiers in Oncology.